Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

A new model for predicting liver cirrhosis in chronic hepatitis B virus carriers with low serum alanine transaminase activity.

Zeng DW, Zhang JM, Liu YR, Dong J, Wu YL, Lin S, Jiang JJ, Zhu YY.

Clin Res Hepatol Gastroenterol. 2014 Dec;38(6):727-34. doi: 10.1016/j.clinre.2014.06.007. Epub 2014 Jul 19.

PMID:
25048838
2.

Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients.

Liu XD, Wu JL, Liang J, Zhang T, Sheng QS.

World J Gastroenterol. 2012 Jun 14;18(22):2784-92. doi: 10.3748/wjg.v18.i22.2784.

3.
4.

Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.

Kim BK, Kim SA, Park YN, Cheong JY, Kim HS, Park JY, Cho SW, Han KH, Chon CY, Moon YM, Ahn SH.

Liver Int. 2007 Sep;27(7):969-76.

PMID:
17696936
5.
6.

Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B.

Lin CL, Liu CH, Wang CC, Liang CC, Su TH, Liu CJ, Kao JH.

J Clin Gastroenterol. 2015 Sep;49(8):705-13. doi: 10.1097/MCG.0000000000000250.

PMID:
25319739
7.

A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B.

Seto WK, Lee CF, Lai CL, Ip PP, Fong DY, Fung J, Wong DK, Yuen MF.

PLoS One. 2011;6(8):e23077. doi: 10.1371/journal.pone.0023077. Epub 2011 Aug 11.

9.

Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.

Karagoz E, Ulcay A, Tanoglu A, Kara M, Turhan V, Erdem H, Oncul O, Gorenek L.

Eur J Gastroenterol Hepatol. 2014 Dec;26(12):1320-4. doi: 10.1097/MEG.0000000000000203.

PMID:
25210777
10.

Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.

Sanai FM, Babatin MA, Bzeizi KI, Alsohaibani F, Al-Hamoudi W, Alsaad KO, Al Mana H, Handoo FA, Al-Ashgar H, Alghamdi H, Ibrahim A, Aljumah A, Alalwan A, Altraif IH, Al-Hussaini H, Myers RP, Abdo AA.

Clin Gastroenterol Hepatol. 2013 Nov;11(11):1493-1499.e2. doi: 10.1016/j.cgh.2013.05.038. Epub 2013 Jun 28.

PMID:
23811251
11.

Non-invasive models for predicting histology in patients with chronic hepatitis B.

Wai CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, Mak B, Oo AM, Lim SG.

Liver Int. 2006 Aug;26(6):666-72.

PMID:
16842322
12.

[A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].

Tu XL, Xiao YQ, Chen F.

Zhonghua Gan Zang Bing Za Zhi. 2009 Jan;17(1):28-32. Chinese.

PMID:
19203448
13.

Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.

Lee KG, Seo YS, An H, Um SH, Jung ES, Keum B, Yim HJ, Jeen YT, Chun HJ, Kim CD, Ryu HS.

J Gastroenterol Hepatol. 2010 Jan;25(1):94-100. doi: 10.1111/j.1440-1746.2009.05953.x. Epub 2009 Sep 27.

PMID:
19793171
14.

Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection.

Ma J, Jiang Y, Gong G.

Eur J Gastroenterol Hepatol. 2013 Apr;25(4):428-34. doi: 10.1097/MEG.0b013e32835cb5dd.

PMID:
23358121
15.

A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis.

Cheong JY, Um SH, Seo YS, Shin SS, Park RW, Kim DJ, Hwang SG, Lee YJ, Cho M, Yang JM, Kim YB, Park YN, Cho SW.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2592-7. doi: 10.5754/hge10157.

PMID:
23178625
16.

Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease.

Zeng DW, Liu YR, Zhang JM, Zhu YY, Lin S, You J, Li YB, Chen J, Zheng Q, Jiang JJ, Dong J.

PLoS One. 2013 Oct 25;8(10):e77942. doi: 10.1371/journal.pone.0077942. eCollection 2013.

17.

How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B?

Kim SU, Kim DY, Park JY, Lee JH, Ahn SH, Kim JK, Paik YH, Lee KS, Chon CY, Choi EH, Song KJ, Park YN, Han KH.

J Clin Gastroenterol. 2010 Jan;44(1):66-71. doi: 10.1097/MCG.0b013e3181a95c7f.

PMID:
19609218
18.

A scoring system for predicting significant fibrosis in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase levels.

Wang H, Yan R, Zhou Y, Wang MS, Ruo GQ, Cheng MJ.

J Clin Gastroenterol. 2015 Jan;49(1):69-75. doi: 10.1097/MCG.0000000000000090.

PMID:
24518795
19.

Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease.

Mohamadnejad M, Montazeri G, Fazlollahi A, Zamani F, Nasiri J, Nobakht H, Forouzanfar MH, Abedian S, Tavangar SM, Mohamadkhani A, Ghoujeghi F, Estakhri A, Nouri N, Farzadi Z, Najjari A, Malekzadeh R.

Am J Gastroenterol. 2006 Nov;101(11):2537-45. Epub 2006 Oct 4.

PMID:
17029616
20.

[Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].

Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH.

Korean J Hepatol. 2009 Dec;15(4):454-63. doi: 10.3350/kjhep.2009.15.4.454. Korean.

Supplemental Content

Support Center